Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
REVIVA PHARMACEUTICALS HOLDINGS, INC. | President and CEO, Director, 10%+ Owner | Stock Option (right to buy) | 443 K | Apr 25, 2023 | Direct | ||
REVIVA PHARMACEUTICALS HOLDINGS, INC. | President and CEO, Director, 10%+ Owner | Stock Option (right to buy) | 150 K | Apr 25, 2023 | By Spouse |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | Apr 25, 2023 | 2 | $0 | 4 | Apr 27, 2023 | President and CEO, Director, 10%+ Owner |